-
1 Comment
Beijing Balance Medical Technology Co.,Ltd is currently in a long term uptrend where the price is trading 73.1% above its 200 day moving average.
From a valuation standpoint, the stock is 572.7% more expensive than other stocks from the None sector with a price to sales ratio of 83.5.
Based on the above factors, Beijing Balance Medical Technology Co.,Ltd gets an overall score of 1/5.
| ISIN | None |
|---|---|
| Exchange | SHG |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Devices |
| PE Ratio | 88.26 |
|---|---|
| Target Price | None |
| Market Cap | 15B |
| Beta | 0.56 |
| Dividend Yield | None |
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valve replacement and repair, congenital heart disease implant intervention, and surgical soft tissue repair applications; and cardiothoracic surgery, neurosurgery, general surgery, and other surgical departments. The company was founded in 2005 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688198.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
